Contact Information

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

PediatricsHematology & Oncology700 Children’s DrColumbus, OH 43205 (map)

Learn more about Rajinder P.S. Bajwa

Biography

Dr. Bajwa’s clinical interests are Bone Marrow Failure Syndromes and BMT. His research interests include veno-occlusive disease, steroid refractory acute graft versus host disease, and chronic health conditions in the long-term survivors after transplant. Other research interests include transplant for high risk conditions, graft failure, and developing reduced intensity conditioning regimen for nonmalignant conditions. He also oversees the comprehensive BMT long-term follow-up clinic and is also involved in research in this patient population including Vitamin D status, metabolic syndrome, and endocrine dysfunction in the long-term survivors after transplant. Dr. Bajwa attended medical school at Punjabi University, Punjab, India and has also done Hem/Onc/BMT training in England, before coming to the United States. He completed his residency and fellowship at Women and Children’s Hospital of Buffalo and Roswell Park Cancer Institute, Buffalo, NY.

Patient Care

Locations

Main Campus of Nationwide Children’s Hospital

Languages Spoken

English Hindi Punjabi Urdu

Academic and Clinical Areas

Blood and Marrow Transplant Clinical Team

Physician Team

Hematology/Oncology & BMT

Physician Team

Bone Marrow Transplant Fellowship

Faculty

Hematology, Oncology and BMT Fellowship

Faculty

Primary Department

Pediatrics

Primary Section

Hematology & Oncology

Research

Publications

                  Di Nardo M, Ahmad AH, Merli P, Zinter MS, Lehman LE, Rowan CM, Steiner ME, Hingorani S, Angelo JR, Abdel-Azim H, Khazal SJ, Shoberu B, McArthur J, Bajwa R, Ghafoor S, Shah SH, Sandhu H, Moody K, Brown BD, Mireles ME, Steppan D, Olson T, Raman L, Bridges B, Duncan CN, Choi SW, Swinford R, Paden M, Fortenberry JD, Peek G, Tissieres P, De Luca D, Locatelli F, Corbacioglu S, Kneyber M, Franceschini A, Nadel S, Kumpf M, Loreti A, Wösten-Van Asperen R, Gawronski O, Brierley J, MacLaren G, Mahadeo KM. Extracorporeal membrane oxygenation in children receiving haematopoietic cell transplantation and immune effector cell therapy: an international and multidisciplinary consensus statement. Lancet Child Adolesc Health. 2021 Dec 9;  

                


                  Bajwa RPS, Taylor K, Hoyt A, Kamboj MK, Stanek J, Mahadeo KM, Alsaedi H, Abdel-Azim H, O'Kane S, Martin PL, Stafford LA, Dvorak CC. Vitamin D has no impact on outcomes after HSCT in children-A retrospective study. Pediatr Transplant. 2021 Jun; 25: e14008.

                


                  Wright M, Rangarajan H, Abu-Arja R, Auletta JJ, Lee D, Polishchuk V, Pai V, Taylor K, Bajwa RPS. Use of belatacept as alternative graft vs host disease prophylaxis in pediatric allogeneic hematopoietic stem cell transplantation. Pediatr Transplant. 2021 May 20;  e14041.

                


                  Boutzoukas AE, Kussman A, Bajwa RPS, Ouellette CP. Disseminated Toxoplasmosis in a Child Following Allogeneic Hematopoietic Cell Transplantation. J Pediatric Infect Dis Soc. 2021 May 28; 10: 698-701.

                


                  Ragoonanan D, Khazal SJ, Abdel-Azim H, McCall D, Cuglievan B, Tambaro FP, Ahmad AH, Rowan CM, Gutierrez C, Schadler K, Li S, Di Nardo M, Chi L, Gulbis AM, Shoberu B, Mireles ME, McArthur J, Kapoor N, Miller J, Fitzgerald JC, Tewari P, Petropoulos D, Gill JB, Duncan CN, Lehmann LE, Hingorani S, Angelo JR, Swinford RD, Steiner ME, Tejada FNH, Martin PL, Auletta J, Choi SW, Bajwa R, Garnes ND, Kebriaei P, Rezvani K, Wierda WG, Neelapu SS, Shpall EJ, Corbacioglu S, Mahadeo KM. Author Correction: Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer. Nat Rev Clin Oncol. 2021 Mar 17;  

                


                  Ragoonanan D, Khazal SJ, Abdel-Azim H, McCall D, Cuglievan B, Tambaro FP, Ahmad AH, Rowan CM, Gutierrez C, Schadler K, Li S, Di Nardo M, Chi L, Gulbis AM, Shoberu B, Mireles ME, McArthur J, Kapoor N, Miller J, Fitzgerald JC, Tewari P, Petropoulos D, Gill JB, Duncan CN, Lehmann LE, Hingorani S, Angelo JR, Swinford RD, Steiner ME, Hernandez Tejada FN, Martin PL, Auletta J, Choi SW, Bajwa R, Dailey Garnes N, Kebriaei P, Rezvani K, Wierda WG, Neelapu SS, Shpall EJ, Corbacioglu S, Mahadeo KM. Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer. Nat Rev Clin Oncol. 2021 Feb 19;  

                


                  Rowan CM, Fitzgerald JC, Agulnik A, Zinter MS, Sharron MP, Slaven JE, Kreml EM, Bajwa RPS, Mahadeo KM, Moffet J, Tarquinio KM, Steiner ME. Risk Factors for Noninvasive Ventilation Failure in Children Post-Hematopoietic Cell Transplant. Front Oncol. 2021; 11: 653607.

                


                  Davidson N, Rangarajan HG, Driest K, Bajwa RPS, Polishchuk V, Abu-Arja RF. Allogeneic Hematopoietic Cell Transplant for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome. Case Rep Rheumatol. 2021; 2021: 9323141.

                


                  Bhunia N, Abu-Arja R, Bajwa RPS, Auletta JJ, Rangarajan HG. Successful treatment with eculizumab for posterior reversible encephalopathy syndrome due to underlying transplant-associated thrombotic microangiopathy in patients transplanted for sickle cell disease. Pediatr Blood Cancer. 2019 Oct; 66: e27912.

                


                  Perisa MP, Rose MJ, Varga E, Kamboj MK, Spencer JD, Bajwa RPS. A novel SAMD9 variant identified in patient with MIRAGE syndrome: Further defining syndromic phenotype and review of previous cases. Pediatr Blood Cancer. 2019 Mar 21;  e27726.

                


                  Mahadeo KM, Khazal SJ, Abdel-Azim H, Fitzgerald JC, Taraseviciute A, Bollard CM, Tewari P, Duncan C, Traube C, McCall D, Steiner ME, Cheifetz IM, Lehmann LE, Mejia R, Slopis JM, Bajwa R, Kebriaei P, Martin PL, Moffet J, McArthur J, Petropoulos D, O'Hanlon Curry J, Featherston S, Foglesong J, Shoberu B, Gulbis A, Mireles ME, Hafemeister L, Nguyen C, Kapoor N, Rezvani K, Neelapu SS, Shpall EJ, Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network.. Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy. Nat Rev Clin Oncol. 2018 Aug 6;  

                


                  Rowan CM, Gertz SJ, Zinter MS, Moffet J, Bajwa RPS, Barnum JL, Kong M, Hematopoietic Cell Transplant group of the Pediatric Acute Lung Injury and Sepsis Investigator (PALISI) network.. A multicenter investigation of respiratory syncytial viral infection in children with hematopoietic cell transplantation. Transpl Infect Dis. 2018 Jun; 20: e12882.

View More Publications

Education

Date of Appointment at Nationwide Children’s Hospital: 07/01/2007

Board Certifications

Pediatric Hematology Oncology Pediatrics

Fellowship

Women and Childrens Hospital of Buffalo

Date Completed: 06/30/2006

Fellowship

University of Minnesota

Date Completed: 04/30/2006

Fellowship

South Tyneside NHS Healthcare

Date Completed: 01/31/2001

Residency

Women and Childrens Hospital of Buffalo

Date Completed: 06/30/2003

Residency

Kent and Canterbury Hospital

Date Completed: 02/28/1997

Residency

Queen Elizabeth The Queen Mother Hospital

Date Completed: 07/31/1996

Residency

Institute of Medical Education/Research

Date Completed: 06/30/1992

Residency

Rajendra Hosp Patiala & Govt Med College

Date Completed: 12/31/1985

Internship

Rajendra Hosp Patiala & Govt Med College

Date Completed: 12/31/1984

Medical School

Punjabi University

Date Completed: 08/24/1985

Contact Information

Pediatrics

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

                    Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)

Contact Information

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

PediatricsHematology & Oncology700 Children’s DrColumbus, OH 43205 (map)

Learn more about Rajinder P.S. Bajwa

Biography

Dr. Bajwa’s clinical interests are Bone Marrow Failure Syndromes and BMT. His research interests include veno-occlusive disease, steroid refractory acute graft versus host disease, and chronic health conditions in the long-term survivors after transplant. Other research interests include transplant for high risk conditions, graft failure, and developing reduced intensity conditioning regimen for nonmalignant conditions. He also oversees the comprehensive BMT long-term follow-up clinic and is also involved in research in this patient population including Vitamin D status, metabolic syndrome, and endocrine dysfunction in the long-term survivors after transplant. Dr. Bajwa attended medical school at Punjabi University, Punjab, India and has also done Hem/Onc/BMT training in England, before coming to the United States. He completed his residency and fellowship at Women and Children’s Hospital of Buffalo and Roswell Park Cancer Institute, Buffalo, NY.

Patient Care

Locations

Main Campus of Nationwide Children’s Hospital

Languages Spoken

English Hindi Punjabi Urdu

Academic and Clinical Areas

Blood and Marrow Transplant Clinical Team

Physician Team

Hematology/Oncology & BMT

Physician Team

Bone Marrow Transplant Fellowship

Faculty

Hematology, Oncology and BMT Fellowship

Faculty

Primary Department

Pediatrics

Primary Section

Hematology & Oncology

Research

Publications

                  Di Nardo M, Ahmad AH, Merli P, Zinter MS, Lehman LE, Rowan CM, Steiner ME, Hingorani S, Angelo JR, Abdel-Azim H, Khazal SJ, Shoberu B, McArthur J, Bajwa R, Ghafoor S, Shah SH, Sandhu H, Moody K, Brown BD, Mireles ME, Steppan D, Olson T, Raman L, Bridges B, Duncan CN, Choi SW, Swinford R, Paden M, Fortenberry JD, Peek G, Tissieres P, De Luca D, Locatelli F, Corbacioglu S, Kneyber M, Franceschini A, Nadel S, Kumpf M, Loreti A, Wösten-Van Asperen R, Gawronski O, Brierley J, MacLaren G, Mahadeo KM. Extracorporeal membrane oxygenation in children receiving haematopoietic cell transplantation and immune effector cell therapy: an international and multidisciplinary consensus statement. Lancet Child Adolesc Health. 2021 Dec 9;  

                


                  Bajwa RPS, Taylor K, Hoyt A, Kamboj MK, Stanek J, Mahadeo KM, Alsaedi H, Abdel-Azim H, O'Kane S, Martin PL, Stafford LA, Dvorak CC. Vitamin D has no impact on outcomes after HSCT in children-A retrospective study. Pediatr Transplant. 2021 Jun; 25: e14008.

                


                  Wright M, Rangarajan H, Abu-Arja R, Auletta JJ, Lee D, Polishchuk V, Pai V, Taylor K, Bajwa RPS. Use of belatacept as alternative graft vs host disease prophylaxis in pediatric allogeneic hematopoietic stem cell transplantation. Pediatr Transplant. 2021 May 20;  e14041.

                


                  Boutzoukas AE, Kussman A, Bajwa RPS, Ouellette CP. Disseminated Toxoplasmosis in a Child Following Allogeneic Hematopoietic Cell Transplantation. J Pediatric Infect Dis Soc. 2021 May 28; 10: 698-701.

                


                  Ragoonanan D, Khazal SJ, Abdel-Azim H, McCall D, Cuglievan B, Tambaro FP, Ahmad AH, Rowan CM, Gutierrez C, Schadler K, Li S, Di Nardo M, Chi L, Gulbis AM, Shoberu B, Mireles ME, McArthur J, Kapoor N, Miller J, Fitzgerald JC, Tewari P, Petropoulos D, Gill JB, Duncan CN, Lehmann LE, Hingorani S, Angelo JR, Swinford RD, Steiner ME, Tejada FNH, Martin PL, Auletta J, Choi SW, Bajwa R, Garnes ND, Kebriaei P, Rezvani K, Wierda WG, Neelapu SS, Shpall EJ, Corbacioglu S, Mahadeo KM. Author Correction: Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer. Nat Rev Clin Oncol. 2021 Mar 17;  

                


                  Ragoonanan D, Khazal SJ, Abdel-Azim H, McCall D, Cuglievan B, Tambaro FP, Ahmad AH, Rowan CM, Gutierrez C, Schadler K, Li S, Di Nardo M, Chi L, Gulbis AM, Shoberu B, Mireles ME, McArthur J, Kapoor N, Miller J, Fitzgerald JC, Tewari P, Petropoulos D, Gill JB, Duncan CN, Lehmann LE, Hingorani S, Angelo JR, Swinford RD, Steiner ME, Hernandez Tejada FN, Martin PL, Auletta J, Choi SW, Bajwa R, Dailey Garnes N, Kebriaei P, Rezvani K, Wierda WG, Neelapu SS, Shpall EJ, Corbacioglu S, Mahadeo KM. Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer. Nat Rev Clin Oncol. 2021 Feb 19;  

                


                  Rowan CM, Fitzgerald JC, Agulnik A, Zinter MS, Sharron MP, Slaven JE, Kreml EM, Bajwa RPS, Mahadeo KM, Moffet J, Tarquinio KM, Steiner ME. Risk Factors for Noninvasive Ventilation Failure in Children Post-Hematopoietic Cell Transplant. Front Oncol. 2021; 11: 653607.

                


                  Davidson N, Rangarajan HG, Driest K, Bajwa RPS, Polishchuk V, Abu-Arja RF. Allogeneic Hematopoietic Cell Transplant for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome. Case Rep Rheumatol. 2021; 2021: 9323141.

                


                  Bhunia N, Abu-Arja R, Bajwa RPS, Auletta JJ, Rangarajan HG. Successful treatment with eculizumab for posterior reversible encephalopathy syndrome due to underlying transplant-associated thrombotic microangiopathy in patients transplanted for sickle cell disease. Pediatr Blood Cancer. 2019 Oct; 66: e27912.

                


                  Perisa MP, Rose MJ, Varga E, Kamboj MK, Spencer JD, Bajwa RPS. A novel SAMD9 variant identified in patient with MIRAGE syndrome: Further defining syndromic phenotype and review of previous cases. Pediatr Blood Cancer. 2019 Mar 21;  e27726.

                


                  Mahadeo KM, Khazal SJ, Abdel-Azim H, Fitzgerald JC, Taraseviciute A, Bollard CM, Tewari P, Duncan C, Traube C, McCall D, Steiner ME, Cheifetz IM, Lehmann LE, Mejia R, Slopis JM, Bajwa R, Kebriaei P, Martin PL, Moffet J, McArthur J, Petropoulos D, O'Hanlon Curry J, Featherston S, Foglesong J, Shoberu B, Gulbis A, Mireles ME, Hafemeister L, Nguyen C, Kapoor N, Rezvani K, Neelapu SS, Shpall EJ, Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network.. Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy. Nat Rev Clin Oncol. 2018 Aug 6;  

                


                  Rowan CM, Gertz SJ, Zinter MS, Moffet J, Bajwa RPS, Barnum JL, Kong M, Hematopoietic Cell Transplant group of the Pediatric Acute Lung Injury and Sepsis Investigator (PALISI) network.. A multicenter investigation of respiratory syncytial viral infection in children with hematopoietic cell transplantation. Transpl Infect Dis. 2018 Jun; 20: e12882.

View More Publications

Education

Date of Appointment at Nationwide Children’s Hospital: 07/01/2007

Board Certifications

Pediatric Hematology Oncology Pediatrics

Fellowship

Women and Childrens Hospital of Buffalo

Date Completed: 06/30/2006

Fellowship

University of Minnesota

Date Completed: 04/30/2006

Fellowship

South Tyneside NHS Healthcare

Date Completed: 01/31/2001

Residency

Women and Childrens Hospital of Buffalo

Date Completed: 06/30/2003

Residency

Kent and Canterbury Hospital

Date Completed: 02/28/1997

Residency

Queen Elizabeth The Queen Mother Hospital

Date Completed: 07/31/1996

Residency

Institute of Medical Education/Research

Date Completed: 06/30/1992

Residency

Rajendra Hosp Patiala & Govt Med College

Date Completed: 12/31/1985

Internship

Rajendra Hosp Patiala & Govt Med College

Date Completed: 12/31/1984

Medical School

Punjabi University

Date Completed: 08/24/1985

Contact Information

Pediatrics

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

                    Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)

Contact Information

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

PediatricsHematology & Oncology700 Children’s DrColumbus, OH 43205 (map)

Learn more about Rajinder P.S. Bajwa

Contact Information

  • Call us at:
  • (614) 722-3550
  • Fax us at:
  • (614) 722-3369
  • PediatricsHematology & Oncology700 Children’s DrColumbus, OH 43205 (map)

Learn more about Rajinder P.S. Bajwa

Biography

Dr. Bajwa’s clinical interests are Bone Marrow Failure Syndromes and BMT. His research interests include veno-occlusive disease, steroid refractory acute graft versus host disease, and chronic health conditions in the long-term survivors after transplant. Other research interests include transplant for high risk conditions, graft failure, and developing reduced intensity conditioning regimen for nonmalignant conditions. He also oversees the comprehensive BMT long-term follow-up clinic and is also involved in research in this patient population including Vitamin D status, metabolic syndrome, and endocrine dysfunction in the long-term survivors after transplant. Dr. Bajwa attended medical school at Punjabi University, Punjab, India and has also done Hem/Onc/BMT training in England, before coming to the United States. He completed his residency and fellowship at Women and Children’s Hospital of Buffalo and Roswell Park Cancer Institute, Buffalo, NY.

Biography

Dr. Bajwa’s clinical interests are Bone Marrow Failure Syndromes and BMT. His research interests include veno-occlusive disease, steroid refractory acute graft versus host disease, and chronic health conditions in the long-term survivors after transplant. Other research interests include transplant for high risk conditions, graft failure, and developing reduced intensity conditioning regimen for nonmalignant conditions. He also oversees the comprehensive BMT long-term follow-up clinic and is also involved in research in this patient population including Vitamin D status, metabolic syndrome, and endocrine dysfunction in the long-term survivors after transplant. Dr. Bajwa attended medical school at Punjabi University, Punjab, India and has also done Hem/Onc/BMT training in England, before coming to the United States. He completed his residency and fellowship at Women and Children’s Hospital of Buffalo and Roswell Park Cancer Institute, Buffalo, NY.

Biography

Dr. Bajwa’s clinical interests are Bone Marrow Failure Syndromes and BMT. His research interests include veno-occlusive disease, steroid refractory acute graft versus host disease, and chronic health conditions in the long-term survivors after transplant. Other research interests include transplant for high risk conditions, graft failure, and developing reduced intensity conditioning regimen for nonmalignant conditions. He also oversees the comprehensive BMT long-term follow-up clinic and is also involved in research in this patient population including Vitamin D status, metabolic syndrome, and endocrine dysfunction in the long-term survivors after transplant. Dr. Bajwa attended medical school at Punjabi University, Punjab, India and has also done Hem/Onc/BMT training in England, before coming to the United States. He completed his residency and fellowship at Women and Children’s Hospital of Buffalo and Roswell Park Cancer Institute, Buffalo, NY.

Dr. Bajwa’s clinical interests are Bone Marrow Failure Syndromes and BMT. His research interests include veno-occlusive disease, steroid refractory acute graft versus host disease, and chronic health conditions in the long-term survivors after transplant. Other research interests include transplant for high risk conditions, graft failure, and developing reduced intensity conditioning regimen for nonmalignant conditions. He also oversees the comprehensive BMT long-term follow-up clinic and is also involved in research in this patient population including Vitamin D status, metabolic syndrome, and endocrine dysfunction in the long-term survivors after transplant. Dr. Bajwa attended medical school at Punjabi University, Punjab, India and has also done Hem/Onc/BMT training in England, before coming to the United States. He completed his residency and fellowship at Women and Children’s Hospital of Buffalo and Roswell Park Cancer Institute, Buffalo, NY.

Dr. Bajwa’s clinical interests are Bone Marrow Failure Syndromes and BMT. His research interests include veno-occlusive disease, steroid refractory acute graft versus host disease, and chronic health conditions in the long-term survivors after transplant. Other research interests include transplant for high risk conditions, graft failure, and developing reduced intensity conditioning regimen for nonmalignant conditions. He also oversees the comprehensive BMT long-term follow-up clinic and is also involved in research in this patient population including Vitamin D status, metabolic syndrome, and endocrine dysfunction in the long-term survivors after transplant. Dr. Bajwa attended medical school at Punjabi University, Punjab, India and has also done Hem/Onc/BMT training in England, before coming to the United States. He completed his residency and fellowship at Women and Children’s Hospital of Buffalo and Roswell Park Cancer Institute, Buffalo, NY.

Patient Care

Locations

Main Campus of Nationwide Children’s Hospital

Languages Spoken

English Hindi Punjabi Urdu

Patient Care

Locations

Main Campus of Nationwide Children’s Hospital

Languages Spoken

English Hindi Punjabi Urdu

Patient Care

Locations

Main Campus of Nationwide Children’s Hospital

Languages Spoken

English Hindi Punjabi Urdu

Locations

Main Campus of Nationwide Children’s Hospital

Languages Spoken

English Hindi Punjabi Urdu

Locations

Main Campus of Nationwide Children’s Hospital

Languages Spoken

English Hindi Punjabi Urdu

Locations

Main Campus of Nationwide Children’s Hospital

Languages Spoken

English Hindi Punjabi Urdu

  • Main Campus of Nationwide Children’s Hospital

  • English

  • Hindi

  • Punjabi

  • Urdu

Academic and Clinical Areas

Blood and Marrow Transplant Clinical Team

Physician Team

Hematology/Oncology & BMT

Physician Team

Bone Marrow Transplant Fellowship

Faculty

Hematology, Oncology and BMT Fellowship

Faculty

Primary Department

Pediatrics

Primary Section

Hematology & Oncology

Academic and Clinical Areas

Blood and Marrow Transplant Clinical Team

Physician Team

Hematology/Oncology & BMT

Physician Team

Bone Marrow Transplant Fellowship

Faculty

Hematology, Oncology and BMT Fellowship

Faculty

Primary Department

Pediatrics

Primary Section

Hematology & Oncology

Academic and Clinical Areas

Blood and Marrow Transplant Clinical Team

Physician Team

Hematology/Oncology & BMT

Physician Team

Bone Marrow Transplant Fellowship

Faculty

Hematology, Oncology and BMT Fellowship

Faculty

Primary Department

Pediatrics

Primary Section

Hematology & Oncology

Blood and Marrow Transplant Clinical Team

Physician Team

Hematology/Oncology & BMT

Physician Team

Bone Marrow Transplant Fellowship

Faculty

Hematology, Oncology and BMT Fellowship

Faculty

Primary Department

Pediatrics

Primary Section

Hematology & Oncology

  • Blood and Marrow Transplant Clinical Team
  • Physician Team
  • Hematology/Oncology & BMT
  • Physician Team
  • Bone Marrow Transplant Fellowship
  • Faculty
  • Hematology, Oncology and BMT Fellowship
  • Faculty
  • Primary Department
  • Pediatrics
  • Primary Section
  • Hematology & Oncology

Research

Publications

                  Di Nardo M, Ahmad AH, Merli P, Zinter MS, Lehman LE, Rowan CM, Steiner ME, Hingorani S, Angelo JR, Abdel-Azim H, Khazal SJ, Shoberu B, McArthur J, Bajwa R, Ghafoor S, Shah SH, Sandhu H, Moody K, Brown BD, Mireles ME, Steppan D, Olson T, Raman L, Bridges B, Duncan CN, Choi SW, Swinford R, Paden M, Fortenberry JD, Peek G, Tissieres P, De Luca D, Locatelli F, Corbacioglu S, Kneyber M, Franceschini A, Nadel S, Kumpf M, Loreti A, Wösten-Van Asperen R, Gawronski O, Brierley J, MacLaren G, Mahadeo KM. Extracorporeal membrane oxygenation in children receiving haematopoietic cell transplantation and immune effector cell therapy: an international and multidisciplinary consensus statement. Lancet Child Adolesc Health. 2021 Dec 9;  

                


                  Bajwa RPS, Taylor K, Hoyt A, Kamboj MK, Stanek J, Mahadeo KM, Alsaedi H, Abdel-Azim H, O'Kane S, Martin PL, Stafford LA, Dvorak CC. Vitamin D has no impact on outcomes after HSCT in children-A retrospective study. Pediatr Transplant. 2021 Jun; 25: e14008.

                


                  Wright M, Rangarajan H, Abu-Arja R, Auletta JJ, Lee D, Polishchuk V, Pai V, Taylor K, Bajwa RPS. Use of belatacept as alternative graft vs host disease prophylaxis in pediatric allogeneic hematopoietic stem cell transplantation. Pediatr Transplant. 2021 May 20;  e14041.

                


                  Boutzoukas AE, Kussman A, Bajwa RPS, Ouellette CP. Disseminated Toxoplasmosis in a Child Following Allogeneic Hematopoietic Cell Transplantation. J Pediatric Infect Dis Soc. 2021 May 28; 10: 698-701.

                


                  Ragoonanan D, Khazal SJ, Abdel-Azim H, McCall D, Cuglievan B, Tambaro FP, Ahmad AH, Rowan CM, Gutierrez C, Schadler K, Li S, Di Nardo M, Chi L, Gulbis AM, Shoberu B, Mireles ME, McArthur J, Kapoor N, Miller J, Fitzgerald JC, Tewari P, Petropoulos D, Gill JB, Duncan CN, Lehmann LE, Hingorani S, Angelo JR, Swinford RD, Steiner ME, Tejada FNH, Martin PL, Auletta J, Choi SW, Bajwa R, Garnes ND, Kebriaei P, Rezvani K, Wierda WG, Neelapu SS, Shpall EJ, Corbacioglu S, Mahadeo KM. Author Correction: Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer. Nat Rev Clin Oncol. 2021 Mar 17;  

                


                  Ragoonanan D, Khazal SJ, Abdel-Azim H, McCall D, Cuglievan B, Tambaro FP, Ahmad AH, Rowan CM, Gutierrez C, Schadler K, Li S, Di Nardo M, Chi L, Gulbis AM, Shoberu B, Mireles ME, McArthur J, Kapoor N, Miller J, Fitzgerald JC, Tewari P, Petropoulos D, Gill JB, Duncan CN, Lehmann LE, Hingorani S, Angelo JR, Swinford RD, Steiner ME, Hernandez Tejada FN, Martin PL, Auletta J, Choi SW, Bajwa R, Dailey Garnes N, Kebriaei P, Rezvani K, Wierda WG, Neelapu SS, Shpall EJ, Corbacioglu S, Mahadeo KM. Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer. Nat Rev Clin Oncol. 2021 Feb 19;  

                


                  Rowan CM, Fitzgerald JC, Agulnik A, Zinter MS, Sharron MP, Slaven JE, Kreml EM, Bajwa RPS, Mahadeo KM, Moffet J, Tarquinio KM, Steiner ME. Risk Factors for Noninvasive Ventilation Failure in Children Post-Hematopoietic Cell Transplant. Front Oncol. 2021; 11: 653607.

                


                  Davidson N, Rangarajan HG, Driest K, Bajwa RPS, Polishchuk V, Abu-Arja RF. Allogeneic Hematopoietic Cell Transplant for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome. Case Rep Rheumatol. 2021; 2021: 9323141.

                


                  Bhunia N, Abu-Arja R, Bajwa RPS, Auletta JJ, Rangarajan HG. Successful treatment with eculizumab for posterior reversible encephalopathy syndrome due to underlying transplant-associated thrombotic microangiopathy in patients transplanted for sickle cell disease. Pediatr Blood Cancer. 2019 Oct; 66: e27912.

                


                  Perisa MP, Rose MJ, Varga E, Kamboj MK, Spencer JD, Bajwa RPS. A novel SAMD9 variant identified in patient with MIRAGE syndrome: Further defining syndromic phenotype and review of previous cases. Pediatr Blood Cancer. 2019 Mar 21;  e27726.

                


                  Mahadeo KM, Khazal SJ, Abdel-Azim H, Fitzgerald JC, Taraseviciute A, Bollard CM, Tewari P, Duncan C, Traube C, McCall D, Steiner ME, Cheifetz IM, Lehmann LE, Mejia R, Slopis JM, Bajwa R, Kebriaei P, Martin PL, Moffet J, McArthur J, Petropoulos D, O'Hanlon Curry J, Featherston S, Foglesong J, Shoberu B, Gulbis A, Mireles ME, Hafemeister L, Nguyen C, Kapoor N, Rezvani K, Neelapu SS, Shpall EJ, Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network.. Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy. Nat Rev Clin Oncol. 2018 Aug 6;  

                


                  Rowan CM, Gertz SJ, Zinter MS, Moffet J, Bajwa RPS, Barnum JL, Kong M, Hematopoietic Cell Transplant group of the Pediatric Acute Lung Injury and Sepsis Investigator (PALISI) network.. A multicenter investigation of respiratory syncytial viral infection in children with hematopoietic cell transplantation. Transpl Infect Dis. 2018 Jun; 20: e12882.

View More Publications

Research

Publications

                  Di Nardo M, Ahmad AH, Merli P, Zinter MS, Lehman LE, Rowan CM, Steiner ME, Hingorani S, Angelo JR, Abdel-Azim H, Khazal SJ, Shoberu B, McArthur J, Bajwa R, Ghafoor S, Shah SH, Sandhu H, Moody K, Brown BD, Mireles ME, Steppan D, Olson T, Raman L, Bridges B, Duncan CN, Choi SW, Swinford R, Paden M, Fortenberry JD, Peek G, Tissieres P, De Luca D, Locatelli F, Corbacioglu S, Kneyber M, Franceschini A, Nadel S, Kumpf M, Loreti A, Wösten-Van Asperen R, Gawronski O, Brierley J, MacLaren G, Mahadeo KM. Extracorporeal membrane oxygenation in children receiving haematopoietic cell transplantation and immune effector cell therapy: an international and multidisciplinary consensus statement. Lancet Child Adolesc Health. 2021 Dec 9;  

                


                  Bajwa RPS, Taylor K, Hoyt A, Kamboj MK, Stanek J, Mahadeo KM, Alsaedi H, Abdel-Azim H, O'Kane S, Martin PL, Stafford LA, Dvorak CC. Vitamin D has no impact on outcomes after HSCT in children-A retrospective study. Pediatr Transplant. 2021 Jun; 25: e14008.

                


                  Wright M, Rangarajan H, Abu-Arja R, Auletta JJ, Lee D, Polishchuk V, Pai V, Taylor K, Bajwa RPS. Use of belatacept as alternative graft vs host disease prophylaxis in pediatric allogeneic hematopoietic stem cell transplantation. Pediatr Transplant. 2021 May 20;  e14041.

                


                  Boutzoukas AE, Kussman A, Bajwa RPS, Ouellette CP. Disseminated Toxoplasmosis in a Child Following Allogeneic Hematopoietic Cell Transplantation. J Pediatric Infect Dis Soc. 2021 May 28; 10: 698-701.

                


                  Ragoonanan D, Khazal SJ, Abdel-Azim H, McCall D, Cuglievan B, Tambaro FP, Ahmad AH, Rowan CM, Gutierrez C, Schadler K, Li S, Di Nardo M, Chi L, Gulbis AM, Shoberu B, Mireles ME, McArthur J, Kapoor N, Miller J, Fitzgerald JC, Tewari P, Petropoulos D, Gill JB, Duncan CN, Lehmann LE, Hingorani S, Angelo JR, Swinford RD, Steiner ME, Tejada FNH, Martin PL, Auletta J, Choi SW, Bajwa R, Garnes ND, Kebriaei P, Rezvani K, Wierda WG, Neelapu SS, Shpall EJ, Corbacioglu S, Mahadeo KM. Author Correction: Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer. Nat Rev Clin Oncol. 2021 Mar 17;  

                


                  Ragoonanan D, Khazal SJ, Abdel-Azim H, McCall D, Cuglievan B, Tambaro FP, Ahmad AH, Rowan CM, Gutierrez C, Schadler K, Li S, Di Nardo M, Chi L, Gulbis AM, Shoberu B, Mireles ME, McArthur J, Kapoor N, Miller J, Fitzgerald JC, Tewari P, Petropoulos D, Gill JB, Duncan CN, Lehmann LE, Hingorani S, Angelo JR, Swinford RD, Steiner ME, Hernandez Tejada FN, Martin PL, Auletta J, Choi SW, Bajwa R, Dailey Garnes N, Kebriaei P, Rezvani K, Wierda WG, Neelapu SS, Shpall EJ, Corbacioglu S, Mahadeo KM. Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer. Nat Rev Clin Oncol. 2021 Feb 19;  

                


                  Rowan CM, Fitzgerald JC, Agulnik A, Zinter MS, Sharron MP, Slaven JE, Kreml EM, Bajwa RPS, Mahadeo KM, Moffet J, Tarquinio KM, Steiner ME. Risk Factors for Noninvasive Ventilation Failure in Children Post-Hematopoietic Cell Transplant. Front Oncol. 2021; 11: 653607.

                


                  Davidson N, Rangarajan HG, Driest K, Bajwa RPS, Polishchuk V, Abu-Arja RF. Allogeneic Hematopoietic Cell Transplant for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome. Case Rep Rheumatol. 2021; 2021: 9323141.

                


                  Bhunia N, Abu-Arja R, Bajwa RPS, Auletta JJ, Rangarajan HG. Successful treatment with eculizumab for posterior reversible encephalopathy syndrome due to underlying transplant-associated thrombotic microangiopathy in patients transplanted for sickle cell disease. Pediatr Blood Cancer. 2019 Oct; 66: e27912.

                


                  Perisa MP, Rose MJ, Varga E, Kamboj MK, Spencer JD, Bajwa RPS. A novel SAMD9 variant identified in patient with MIRAGE syndrome: Further defining syndromic phenotype and review of previous cases. Pediatr Blood Cancer. 2019 Mar 21;  e27726.

                


                  Mahadeo KM, Khazal SJ, Abdel-Azim H, Fitzgerald JC, Taraseviciute A, Bollard CM, Tewari P, Duncan C, Traube C, McCall D, Steiner ME, Cheifetz IM, Lehmann LE, Mejia R, Slopis JM, Bajwa R, Kebriaei P, Martin PL, Moffet J, McArthur J, Petropoulos D, O'Hanlon Curry J, Featherston S, Foglesong J, Shoberu B, Gulbis A, Mireles ME, Hafemeister L, Nguyen C, Kapoor N, Rezvani K, Neelapu SS, Shpall EJ, Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network.. Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy. Nat Rev Clin Oncol. 2018 Aug 6;  

                


                  Rowan CM, Gertz SJ, Zinter MS, Moffet J, Bajwa RPS, Barnum JL, Kong M, Hematopoietic Cell Transplant group of the Pediatric Acute Lung Injury and Sepsis Investigator (PALISI) network.. A multicenter investigation of respiratory syncytial viral infection in children with hematopoietic cell transplantation. Transpl Infect Dis. 2018 Jun; 20: e12882.

View More Publications

Research

Publications

                  Di Nardo M, Ahmad AH, Merli P, Zinter MS, Lehman LE, Rowan CM, Steiner ME, Hingorani S, Angelo JR, Abdel-Azim H, Khazal SJ, Shoberu B, McArthur J, Bajwa R, Ghafoor S, Shah SH, Sandhu H, Moody K, Brown BD, Mireles ME, Steppan D, Olson T, Raman L, Bridges B, Duncan CN, Choi SW, Swinford R, Paden M, Fortenberry JD, Peek G, Tissieres P, De Luca D, Locatelli F, Corbacioglu S, Kneyber M, Franceschini A, Nadel S, Kumpf M, Loreti A, Wösten-Van Asperen R, Gawronski O, Brierley J, MacLaren G, Mahadeo KM. Extracorporeal membrane oxygenation in children receiving haematopoietic cell transplantation and immune effector cell therapy: an international and multidisciplinary consensus statement. Lancet Child Adolesc Health. 2021 Dec 9;  

                


                  Bajwa RPS, Taylor K, Hoyt A, Kamboj MK, Stanek J, Mahadeo KM, Alsaedi H, Abdel-Azim H, O'Kane S, Martin PL, Stafford LA, Dvorak CC. Vitamin D has no impact on outcomes after HSCT in children-A retrospective study. Pediatr Transplant. 2021 Jun; 25: e14008.

                


                  Wright M, Rangarajan H, Abu-Arja R, Auletta JJ, Lee D, Polishchuk V, Pai V, Taylor K, Bajwa RPS. Use of belatacept as alternative graft vs host disease prophylaxis in pediatric allogeneic hematopoietic stem cell transplantation. Pediatr Transplant. 2021 May 20;  e14041.

                


                  Boutzoukas AE, Kussman A, Bajwa RPS, Ouellette CP. Disseminated Toxoplasmosis in a Child Following Allogeneic Hematopoietic Cell Transplantation. J Pediatric Infect Dis Soc. 2021 May 28; 10: 698-701.

                


                  Ragoonanan D, Khazal SJ, Abdel-Azim H, McCall D, Cuglievan B, Tambaro FP, Ahmad AH, Rowan CM, Gutierrez C, Schadler K, Li S, Di Nardo M, Chi L, Gulbis AM, Shoberu B, Mireles ME, McArthur J, Kapoor N, Miller J, Fitzgerald JC, Tewari P, Petropoulos D, Gill JB, Duncan CN, Lehmann LE, Hingorani S, Angelo JR, Swinford RD, Steiner ME, Tejada FNH, Martin PL, Auletta J, Choi SW, Bajwa R, Garnes ND, Kebriaei P, Rezvani K, Wierda WG, Neelapu SS, Shpall EJ, Corbacioglu S, Mahadeo KM. Author Correction: Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer. Nat Rev Clin Oncol. 2021 Mar 17;  

                


                  Ragoonanan D, Khazal SJ, Abdel-Azim H, McCall D, Cuglievan B, Tambaro FP, Ahmad AH, Rowan CM, Gutierrez C, Schadler K, Li S, Di Nardo M, Chi L, Gulbis AM, Shoberu B, Mireles ME, McArthur J, Kapoor N, Miller J, Fitzgerald JC, Tewari P, Petropoulos D, Gill JB, Duncan CN, Lehmann LE, Hingorani S, Angelo JR, Swinford RD, Steiner ME, Hernandez Tejada FN, Martin PL, Auletta J, Choi SW, Bajwa R, Dailey Garnes N, Kebriaei P, Rezvani K, Wierda WG, Neelapu SS, Shpall EJ, Corbacioglu S, Mahadeo KM. Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer. Nat Rev Clin Oncol. 2021 Feb 19;  

                


                  Rowan CM, Fitzgerald JC, Agulnik A, Zinter MS, Sharron MP, Slaven JE, Kreml EM, Bajwa RPS, Mahadeo KM, Moffet J, Tarquinio KM, Steiner ME. Risk Factors for Noninvasive Ventilation Failure in Children Post-Hematopoietic Cell Transplant. Front Oncol. 2021; 11: 653607.

                


                  Davidson N, Rangarajan HG, Driest K, Bajwa RPS, Polishchuk V, Abu-Arja RF. Allogeneic Hematopoietic Cell Transplant for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome. Case Rep Rheumatol. 2021; 2021: 9323141.

                


                  Bhunia N, Abu-Arja R, Bajwa RPS, Auletta JJ, Rangarajan HG. Successful treatment with eculizumab for posterior reversible encephalopathy syndrome due to underlying transplant-associated thrombotic microangiopathy in patients transplanted for sickle cell disease. Pediatr Blood Cancer. 2019 Oct; 66: e27912.

                


                  Perisa MP, Rose MJ, Varga E, Kamboj MK, Spencer JD, Bajwa RPS. A novel SAMD9 variant identified in patient with MIRAGE syndrome: Further defining syndromic phenotype and review of previous cases. Pediatr Blood Cancer. 2019 Mar 21;  e27726.

                


                  Mahadeo KM, Khazal SJ, Abdel-Azim H, Fitzgerald JC, Taraseviciute A, Bollard CM, Tewari P, Duncan C, Traube C, McCall D, Steiner ME, Cheifetz IM, Lehmann LE, Mejia R, Slopis JM, Bajwa R, Kebriaei P, Martin PL, Moffet J, McArthur J, Petropoulos D, O'Hanlon Curry J, Featherston S, Foglesong J, Shoberu B, Gulbis A, Mireles ME, Hafemeister L, Nguyen C, Kapoor N, Rezvani K, Neelapu SS, Shpall EJ, Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network.. Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy. Nat Rev Clin Oncol. 2018 Aug 6;  

                


                  Rowan CM, Gertz SJ, Zinter MS, Moffet J, Bajwa RPS, Barnum JL, Kong M, Hematopoietic Cell Transplant group of the Pediatric Acute Lung Injury and Sepsis Investigator (PALISI) network.. A multicenter investigation of respiratory syncytial viral infection in children with hematopoietic cell transplantation. Transpl Infect Dis. 2018 Jun; 20: e12882.

View More Publications

Publications

                  Di Nardo M, Ahmad AH, Merli P, Zinter MS, Lehman LE, Rowan CM, Steiner ME, Hingorani S, Angelo JR, Abdel-Azim H, Khazal SJ, Shoberu B, McArthur J, Bajwa R, Ghafoor S, Shah SH, Sandhu H, Moody K, Brown BD, Mireles ME, Steppan D, Olson T, Raman L, Bridges B, Duncan CN, Choi SW, Swinford R, Paden M, Fortenberry JD, Peek G, Tissieres P, De Luca D, Locatelli F, Corbacioglu S, Kneyber M, Franceschini A, Nadel S, Kumpf M, Loreti A, Wösten-Van Asperen R, Gawronski O, Brierley J, MacLaren G, Mahadeo KM. Extracorporeal membrane oxygenation in children receiving haematopoietic cell transplantation and immune effector cell therapy: an international and multidisciplinary consensus statement. Lancet Child Adolesc Health. 2021 Dec 9;  

                


                  Bajwa RPS, Taylor K, Hoyt A, Kamboj MK, Stanek J, Mahadeo KM, Alsaedi H, Abdel-Azim H, O'Kane S, Martin PL, Stafford LA, Dvorak CC. Vitamin D has no impact on outcomes after HSCT in children-A retrospective study. Pediatr Transplant. 2021 Jun; 25: e14008.

                


                  Wright M, Rangarajan H, Abu-Arja R, Auletta JJ, Lee D, Polishchuk V, Pai V, Taylor K, Bajwa RPS. Use of belatacept as alternative graft vs host disease prophylaxis in pediatric allogeneic hematopoietic stem cell transplantation. Pediatr Transplant. 2021 May 20;  e14041.

                


                  Boutzoukas AE, Kussman A, Bajwa RPS, Ouellette CP. Disseminated Toxoplasmosis in a Child Following Allogeneic Hematopoietic Cell Transplantation. J Pediatric Infect Dis Soc. 2021 May 28; 10: 698-701.

                


                  Ragoonanan D, Khazal SJ, Abdel-Azim H, McCall D, Cuglievan B, Tambaro FP, Ahmad AH, Rowan CM, Gutierrez C, Schadler K, Li S, Di Nardo M, Chi L, Gulbis AM, Shoberu B, Mireles ME, McArthur J, Kapoor N, Miller J, Fitzgerald JC, Tewari P, Petropoulos D, Gill JB, Duncan CN, Lehmann LE, Hingorani S, Angelo JR, Swinford RD, Steiner ME, Tejada FNH, Martin PL, Auletta J, Choi SW, Bajwa R, Garnes ND, Kebriaei P, Rezvani K, Wierda WG, Neelapu SS, Shpall EJ, Corbacioglu S, Mahadeo KM. Author Correction: Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer. Nat Rev Clin Oncol. 2021 Mar 17;  

                


                  Ragoonanan D, Khazal SJ, Abdel-Azim H, McCall D, Cuglievan B, Tambaro FP, Ahmad AH, Rowan CM, Gutierrez C, Schadler K, Li S, Di Nardo M, Chi L, Gulbis AM, Shoberu B, Mireles ME, McArthur J, Kapoor N, Miller J, Fitzgerald JC, Tewari P, Petropoulos D, Gill JB, Duncan CN, Lehmann LE, Hingorani S, Angelo JR, Swinford RD, Steiner ME, Hernandez Tejada FN, Martin PL, Auletta J, Choi SW, Bajwa R, Dailey Garnes N, Kebriaei P, Rezvani K, Wierda WG, Neelapu SS, Shpall EJ, Corbacioglu S, Mahadeo KM. Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer. Nat Rev Clin Oncol. 2021 Feb 19;  

                


                  Rowan CM, Fitzgerald JC, Agulnik A, Zinter MS, Sharron MP, Slaven JE, Kreml EM, Bajwa RPS, Mahadeo KM, Moffet J, Tarquinio KM, Steiner ME. Risk Factors for Noninvasive Ventilation Failure in Children Post-Hematopoietic Cell Transplant. Front Oncol. 2021; 11: 653607.

                


                  Davidson N, Rangarajan HG, Driest K, Bajwa RPS, Polishchuk V, Abu-Arja RF. Allogeneic Hematopoietic Cell Transplant for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome. Case Rep Rheumatol. 2021; 2021: 9323141.

                


                  Bhunia N, Abu-Arja R, Bajwa RPS, Auletta JJ, Rangarajan HG. Successful treatment with eculizumab for posterior reversible encephalopathy syndrome due to underlying transplant-associated thrombotic microangiopathy in patients transplanted for sickle cell disease. Pediatr Blood Cancer. 2019 Oct; 66: e27912.

                


                  Perisa MP, Rose MJ, Varga E, Kamboj MK, Spencer JD, Bajwa RPS. A novel SAMD9 variant identified in patient with MIRAGE syndrome: Further defining syndromic phenotype and review of previous cases. Pediatr Blood Cancer. 2019 Mar 21;  e27726.

                


                  Mahadeo KM, Khazal SJ, Abdel-Azim H, Fitzgerald JC, Taraseviciute A, Bollard CM, Tewari P, Duncan C, Traube C, McCall D, Steiner ME, Cheifetz IM, Lehmann LE, Mejia R, Slopis JM, Bajwa R, Kebriaei P, Martin PL, Moffet J, McArthur J, Petropoulos D, O'Hanlon Curry J, Featherston S, Foglesong J, Shoberu B, Gulbis A, Mireles ME, Hafemeister L, Nguyen C, Kapoor N, Rezvani K, Neelapu SS, Shpall EJ, Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network.. Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy. Nat Rev Clin Oncol. 2018 Aug 6;  

                


                  Rowan CM, Gertz SJ, Zinter MS, Moffet J, Bajwa RPS, Barnum JL, Kong M, Hematopoietic Cell Transplant group of the Pediatric Acute Lung Injury and Sepsis Investigator (PALISI) network.. A multicenter investigation of respiratory syncytial viral infection in children with hematopoietic cell transplantation. Transpl Infect Dis. 2018 Jun; 20: e12882.

View More Publications

                  Di Nardo M, Ahmad AH, Merli P, Zinter MS, Lehman LE, Rowan CM, Steiner ME, Hingorani S, Angelo JR, Abdel-Azim H, Khazal SJ, Shoberu B, McArthur J, Bajwa R, Ghafoor S, Shah SH, Sandhu H, Moody K, Brown BD, Mireles ME, Steppan D, Olson T, Raman L, Bridges B, Duncan CN, Choi SW, Swinford R, Paden M, Fortenberry JD, Peek G, Tissieres P, De Luca D, Locatelli F, Corbacioglu S, Kneyber M, Franceschini A, Nadel S, Kumpf M, Loreti A, Wösten-Van Asperen R, Gawronski O, Brierley J, MacLaren G, Mahadeo KM. Extracorporeal membrane oxygenation in children receiving haematopoietic cell transplantation and immune effector cell therapy: an international and multidisciplinary consensus statement. Lancet Child Adolesc Health. 2021 Dec 9;  

                


                  Bajwa RPS, Taylor K, Hoyt A, Kamboj MK, Stanek J, Mahadeo KM, Alsaedi H, Abdel-Azim H, O'Kane S, Martin PL, Stafford LA, Dvorak CC. Vitamin D has no impact on outcomes after HSCT in children-A retrospective study. Pediatr Transplant. 2021 Jun; 25: e14008.

                


                  Wright M, Rangarajan H, Abu-Arja R, Auletta JJ, Lee D, Polishchuk V, Pai V, Taylor K, Bajwa RPS. Use of belatacept as alternative graft vs host disease prophylaxis in pediatric allogeneic hematopoietic stem cell transplantation. Pediatr Transplant. 2021 May 20;  e14041.

                


                  Boutzoukas AE, Kussman A, Bajwa RPS, Ouellette CP. Disseminated Toxoplasmosis in a Child Following Allogeneic Hematopoietic Cell Transplantation. J Pediatric Infect Dis Soc. 2021 May 28; 10: 698-701.

                


                  Ragoonanan D, Khazal SJ, Abdel-Azim H, McCall D, Cuglievan B, Tambaro FP, Ahmad AH, Rowan CM, Gutierrez C, Schadler K, Li S, Di Nardo M, Chi L, Gulbis AM, Shoberu B, Mireles ME, McArthur J, Kapoor N, Miller J, Fitzgerald JC, Tewari P, Petropoulos D, Gill JB, Duncan CN, Lehmann LE, Hingorani S, Angelo JR, Swinford RD, Steiner ME, Tejada FNH, Martin PL, Auletta J, Choi SW, Bajwa R, Garnes ND, Kebriaei P, Rezvani K, Wierda WG, Neelapu SS, Shpall EJ, Corbacioglu S, Mahadeo KM. Author Correction: Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer. Nat Rev Clin Oncol. 2021 Mar 17;  

                


                  Ragoonanan D, Khazal SJ, Abdel-Azim H, McCall D, Cuglievan B, Tambaro FP, Ahmad AH, Rowan CM, Gutierrez C, Schadler K, Li S, Di Nardo M, Chi L, Gulbis AM, Shoberu B, Mireles ME, McArthur J, Kapoor N, Miller J, Fitzgerald JC, Tewari P, Petropoulos D, Gill JB, Duncan CN, Lehmann LE, Hingorani S, Angelo JR, Swinford RD, Steiner ME, Hernandez Tejada FN, Martin PL, Auletta J, Choi SW, Bajwa R, Dailey Garnes N, Kebriaei P, Rezvani K, Wierda WG, Neelapu SS, Shpall EJ, Corbacioglu S, Mahadeo KM. Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer. Nat Rev Clin Oncol. 2021 Feb 19;  

                


                  Rowan CM, Fitzgerald JC, Agulnik A, Zinter MS, Sharron MP, Slaven JE, Kreml EM, Bajwa RPS, Mahadeo KM, Moffet J, Tarquinio KM, Steiner ME. Risk Factors for Noninvasive Ventilation Failure in Children Post-Hematopoietic Cell Transplant. Front Oncol. 2021; 11: 653607.

                


                  Davidson N, Rangarajan HG, Driest K, Bajwa RPS, Polishchuk V, Abu-Arja RF. Allogeneic Hematopoietic Cell Transplant for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome. Case Rep Rheumatol. 2021; 2021: 9323141.

                


                  Bhunia N, Abu-Arja R, Bajwa RPS, Auletta JJ, Rangarajan HG. Successful treatment with eculizumab for posterior reversible encephalopathy syndrome due to underlying transplant-associated thrombotic microangiopathy in patients transplanted for sickle cell disease. Pediatr Blood Cancer. 2019 Oct; 66: e27912.

                


                  Perisa MP, Rose MJ, Varga E, Kamboj MK, Spencer JD, Bajwa RPS. A novel SAMD9 variant identified in patient with MIRAGE syndrome: Further defining syndromic phenotype and review of previous cases. Pediatr Blood Cancer. 2019 Mar 21;  e27726.

                


                  Mahadeo KM, Khazal SJ, Abdel-Azim H, Fitzgerald JC, Taraseviciute A, Bollard CM, Tewari P, Duncan C, Traube C, McCall D, Steiner ME, Cheifetz IM, Lehmann LE, Mejia R, Slopis JM, Bajwa R, Kebriaei P, Martin PL, Moffet J, McArthur J, Petropoulos D, O'Hanlon Curry J, Featherston S, Foglesong J, Shoberu B, Gulbis A, Mireles ME, Hafemeister L, Nguyen C, Kapoor N, Rezvani K, Neelapu SS, Shpall EJ, Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network.. Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy. Nat Rev Clin Oncol. 2018 Aug 6;  

                


                  Rowan CM, Gertz SJ, Zinter MS, Moffet J, Bajwa RPS, Barnum JL, Kong M, Hematopoietic Cell Transplant group of the Pediatric Acute Lung Injury and Sepsis Investigator (PALISI) network.. A multicenter investigation of respiratory syncytial viral infection in children with hematopoietic cell transplantation. Transpl Infect Dis. 2018 Jun; 20: e12882.

View More Publications

  • Di Nardo M, Ahmad AH, Merli P, Zinter MS, Lehman LE, Rowan CM, Steiner ME, Hingorani S, Angelo JR, Abdel-Azim H, Khazal SJ, Shoberu B, McArthur J, Bajwa R, Ghafoor S, Shah SH, Sandhu H, Moody K, Brown BD, Mireles ME, Steppan D, Olson T, Raman L, Bridges B, Duncan CN, Choi SW, Swinford R, Paden M, Fortenberry JD, Peek G, Tissieres P, De Luca D, Locatelli F, Corbacioglu S, Kneyber M, Franceschini A, Nadel S, Kumpf M, Loreti A, Wösten-Van Asperen R, Gawronski O, Brierley J, MacLaren G, Mahadeo KM. Extracorporeal membrane oxygenation in children receiving haematopoietic cell transplantation and immune effector cell therapy: an international and multidisciplinary consensus statement. Lancet Child Adolesc Health. 2021 Dec 9;
  • Bajwa RPS, Taylor K, Hoyt A, Kamboj MK, Stanek J, Mahadeo KM, Alsaedi H, Abdel-Azim H, O’Kane S, Martin PL, Stafford LA, Dvorak CC. Vitamin D has no impact on outcomes after HSCT in children-A retrospective study. Pediatr Transplant. 2021 Jun; 25: e14008.
  • Wright M, Rangarajan H, Abu-Arja R, Auletta JJ, Lee D, Polishchuk V, Pai V, Taylor K, Bajwa RPS. Use of belatacept as alternative graft vs host disease prophylaxis in pediatric allogeneic hematopoietic stem cell transplantation. Pediatr Transplant. 2021 May 20; e14041.
  • Boutzoukas AE, Kussman A, Bajwa RPS, Ouellette CP. Disseminated Toxoplasmosis in a Child Following Allogeneic Hematopoietic Cell Transplantation. J Pediatric Infect Dis Soc. 2021 May 28; 10: 698-701.
  • Ragoonanan D, Khazal SJ, Abdel-Azim H, McCall D, Cuglievan B, Tambaro FP, Ahmad AH, Rowan CM, Gutierrez C, Schadler K, Li S, Di Nardo M, Chi L, Gulbis AM, Shoberu B, Mireles ME, McArthur J, Kapoor N, Miller J, Fitzgerald JC, Tewari P, Petropoulos D, Gill JB, Duncan CN, Lehmann LE, Hingorani S, Angelo JR, Swinford RD, Steiner ME, Tejada FNH, Martin PL, Auletta J, Choi SW, Bajwa R, Garnes ND, Kebriaei P, Rezvani K, Wierda WG, Neelapu SS, Shpall EJ, Corbacioglu S, Mahadeo KM. Author Correction: Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer. Nat Rev Clin Oncol. 2021 Mar 17;
  • Ragoonanan D, Khazal SJ, Abdel-Azim H, McCall D, Cuglievan B, Tambaro FP, Ahmad AH, Rowan CM, Gutierrez C, Schadler K, Li S, Di Nardo M, Chi L, Gulbis AM, Shoberu B, Mireles ME, McArthur J, Kapoor N, Miller J, Fitzgerald JC, Tewari P, Petropoulos D, Gill JB, Duncan CN, Lehmann LE, Hingorani S, Angelo JR, Swinford RD, Steiner ME, Hernandez Tejada FN, Martin PL, Auletta J, Choi SW, Bajwa R, Dailey Garnes N, Kebriaei P, Rezvani K, Wierda WG, Neelapu SS, Shpall EJ, Corbacioglu S, Mahadeo KM. Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer. Nat Rev Clin Oncol. 2021 Feb 19;
  • Rowan CM, Fitzgerald JC, Agulnik A, Zinter MS, Sharron MP, Slaven JE, Kreml EM, Bajwa RPS, Mahadeo KM, Moffet J, Tarquinio KM, Steiner ME. Risk Factors for Noninvasive Ventilation Failure in Children Post-Hematopoietic Cell Transplant. Front Oncol. 2021; 11: 653607.
  • Davidson N, Rangarajan HG, Driest K, Bajwa RPS, Polishchuk V, Abu-Arja RF. Allogeneic Hematopoietic Cell Transplant for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome. Case Rep Rheumatol. 2021; 2021: 9323141.
  • Bhunia N, Abu-Arja R, Bajwa RPS, Auletta JJ, Rangarajan HG. Successful treatment with eculizumab for posterior reversible encephalopathy syndrome due to underlying transplant-associated thrombotic microangiopathy in patients transplanted for sickle cell disease. Pediatr Blood Cancer. 2019 Oct; 66: e27912.
  • Perisa MP, Rose MJ, Varga E, Kamboj MK, Spencer JD, Bajwa RPS. A novel SAMD9 variant identified in patient with MIRAGE syndrome: Further defining syndromic phenotype and review of previous cases. Pediatr Blood Cancer. 2019 Mar 21; e27726.
  • Mahadeo KM, Khazal SJ, Abdel-Azim H, Fitzgerald JC, Taraseviciute A, Bollard CM, Tewari P, Duncan C, Traube C, McCall D, Steiner ME, Cheifetz IM, Lehmann LE, Mejia R, Slopis JM, Bajwa R, Kebriaei P, Martin PL, Moffet J, McArthur J, Petropoulos D, O’Hanlon Curry J, Featherston S, Foglesong J, Shoberu B, Gulbis A, Mireles ME, Hafemeister L, Nguyen C, Kapoor N, Rezvani K, Neelapu SS, Shpall EJ, Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network.. Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy. Nat Rev Clin Oncol. 2018 Aug 6;
  • Rowan CM, Gertz SJ, Zinter MS, Moffet J, Bajwa RPS, Barnum JL, Kong M, Hematopoietic Cell Transplant group of the Pediatric Acute Lung Injury and Sepsis Investigator (PALISI) network.. A multicenter investigation of respiratory syncytial viral infection in children with hematopoietic cell transplantation. Transpl Infect Dis. 2018 Jun; 20: e12882.

Education

Date of Appointment at Nationwide Children’s Hospital: 07/01/2007

Board Certifications

Pediatric Hematology Oncology Pediatrics

Fellowship

Women and Childrens Hospital of Buffalo

Date Completed: 06/30/2006

Fellowship

University of Minnesota

Date Completed: 04/30/2006

Fellowship

South Tyneside NHS Healthcare

Date Completed: 01/31/2001

Residency

Women and Childrens Hospital of Buffalo

Date Completed: 06/30/2003

Residency

Kent and Canterbury Hospital

Date Completed: 02/28/1997

Residency

Queen Elizabeth The Queen Mother Hospital

Date Completed: 07/31/1996

Residency

Institute of Medical Education/Research

Date Completed: 06/30/1992

Residency

Rajendra Hosp Patiala & Govt Med College

Date Completed: 12/31/1985

Internship

Rajendra Hosp Patiala & Govt Med College

Date Completed: 12/31/1984

Medical School

Punjabi University

Date Completed: 08/24/1985

Education

Date of Appointment at Nationwide Children’s Hospital: 07/01/2007

Board Certifications

Pediatric Hematology Oncology Pediatrics

Fellowship

Women and Childrens Hospital of Buffalo

Date Completed: 06/30/2006

Fellowship

University of Minnesota

Date Completed: 04/30/2006

Fellowship

South Tyneside NHS Healthcare

Date Completed: 01/31/2001

Residency

Women and Childrens Hospital of Buffalo

Date Completed: 06/30/2003

Residency

Kent and Canterbury Hospital

Date Completed: 02/28/1997

Residency

Queen Elizabeth The Queen Mother Hospital

Date Completed: 07/31/1996

Residency

Institute of Medical Education/Research

Date Completed: 06/30/1992

Residency

Rajendra Hosp Patiala & Govt Med College

Date Completed: 12/31/1985

Internship

Rajendra Hosp Patiala & Govt Med College

Date Completed: 12/31/1984

Medical School

Punjabi University

Date Completed: 08/24/1985

Education

Date of Appointment at Nationwide Children’s Hospital: 07/01/2007

Board Certifications

Pediatric Hematology Oncology Pediatrics

Fellowship

Women and Childrens Hospital of Buffalo

Date Completed: 06/30/2006

Fellowship

University of Minnesota

Date Completed: 04/30/2006

Fellowship

South Tyneside NHS Healthcare

Date Completed: 01/31/2001

Residency

Women and Childrens Hospital of Buffalo

Date Completed: 06/30/2003

Residency

Kent and Canterbury Hospital

Date Completed: 02/28/1997

Residency

Queen Elizabeth The Queen Mother Hospital

Date Completed: 07/31/1996

Residency

Institute of Medical Education/Research

Date Completed: 06/30/1992

Residency

Rajendra Hosp Patiala & Govt Med College

Date Completed: 12/31/1985

Internship

Rajendra Hosp Patiala & Govt Med College

Date Completed: 12/31/1984

Medical School

Punjabi University

Date Completed: 08/24/1985

Date of Appointment at Nationwide Children’s Hospital: 07/01/2007

Board Certifications

Pediatric Hematology Oncology Pediatrics

Fellowship

Women and Childrens Hospital of Buffalo

Date Completed: 06/30/2006

Fellowship

University of Minnesota

Date Completed: 04/30/2006

Fellowship

South Tyneside NHS Healthcare

Date Completed: 01/31/2001

Residency

Women and Childrens Hospital of Buffalo

Date Completed: 06/30/2003

Residency

Kent and Canterbury Hospital

Date Completed: 02/28/1997

Residency

Queen Elizabeth The Queen Mother Hospital

Date Completed: 07/31/1996

Residency

Institute of Medical Education/Research

Date Completed: 06/30/1992

Residency

Rajendra Hosp Patiala & Govt Med College

Date Completed: 12/31/1985

Internship

Rajendra Hosp Patiala & Govt Med College

Date Completed: 12/31/1984

Medical School

Punjabi University

Date Completed: 08/24/1985

Date of Appointment at Nationwide Children’s Hospital: 07/01/2007

Board Certifications

Pediatric Hematology Oncology Pediatrics

Fellowship

Women and Childrens Hospital of Buffalo

Date Completed: 06/30/2006

Fellowship

University of Minnesota

Date Completed: 04/30/2006

Fellowship

South Tyneside NHS Healthcare

Date Completed: 01/31/2001

Residency

Women and Childrens Hospital of Buffalo

Date Completed: 06/30/2003

Residency

Kent and Canterbury Hospital

Date Completed: 02/28/1997

Residency

Queen Elizabeth The Queen Mother Hospital

Date Completed: 07/31/1996

Residency

Institute of Medical Education/Research

Date Completed: 06/30/1992

Residency

Rajendra Hosp Patiala & Govt Med College

Date Completed: 12/31/1985

Internship

Rajendra Hosp Patiala & Govt Med College

Date Completed: 12/31/1984

Medical School

Punjabi University

Date Completed: 08/24/1985

  • Pediatric Hematology Oncology
  • Pediatrics

Contact Information

Pediatrics

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

                    Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)

Contact Information

Pediatrics

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

                    Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)

Contact Information

Pediatrics

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

                    Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)

Pediatrics

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

                    Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

                    Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

                    Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)
  • Call us at:
  • (614) 722-3550
  • Fax us at:
  • (614) 722-3369
  • Hematology & Oncology700 Children’s DrColumbus, OH 43205 (map)